Human interleukin 1 is a cytocidal factor for several tumor cell lines

Area of Science:

• Immunology
• Cell Biology
• Oncology

Background:

• Interleukin 1 (IL 1) is a cytokine involved in immune responses.
• The cytotoxic potential of IL 1 against tumor cells is not fully understood.
• Understanding cytokine-mediated anti-tumor activity is crucial for developing new cancer therapies.

Purpose of the Study:

• To investigate the growth inhibitory and cytocidal effects of purified IL 1 on a human melanoma cell line (A375).
• To compare the target cell selectivity of IL 1 with that of alpha-lymphotoxin (alpha-LT).
• To determine if IL 1 possesses antiviral activity and if it is antigenically distinct from other cytokines.

Main Methods:

• Purification of IL 1 from stimulated human monocytes.
• Cell culture experiments using human melanoma (A375), mouse fibroblast (L929), HeLa, HOS, and TU5 cell lines.
• Chromatography (conventional and HPLC) to assess IL 1 activity.
• ELISA and radioimmunoassays to evaluate antigenic distinctness from other cytokines.

Main Results:

• Highly purified IL 1 exhibited irreversible growth inhibition and cytocidal effects on the A375 melanoma cell line.
• IL 1 showed partial growth inhibition and cytocidal activity against LT-sensitive L929 cells but not against LT-resistant cell lines.
• IL 1 activity was antigenically distinct from alpha-LT, tumor necrosis factor, and IFN-gamma, and lacked antiviral activity.

Conclusions:

• IL 1 possesses significant cytocidal activity against human melanoma cells.
• The target cell selectivity of IL 1 partially overlaps with that of alpha-LT.
• These in vitro findings suggest IL 1 may function as a cytocidal factor in host defense against certain tumors.